1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from U. S. and low- and middle-income country (LMIC) institutions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Joint applications from U. S. and low- and middle-income country (LMIC) institutions. Confirm the full requirements in the official notice before applying.
Global Infectious Disease (GID) Research Training programs is funded by National Institutes of Health (NIH) - Fogarty International Center (FIC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Digital Health Technology and Reciprocal Innovation to Improve Clinical and Public Health Outcomes is sponsored by National Institutes of Health (NIH) - Fogarty International Center (FIC). This initiative supports research on the development, validation, feasibility, and effectiveness of innovative digital health interventions or tools (including mobile health) specifically suited for underserved settings in the U.S. and globally. It emphasizes reciprocal innovation methodologies, which involve a bidirectional exchange of ideas and resources to address shared health challenges between U.S. and low- and middle-income country (LMIC) researchers.
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) - Fogarty International Center (FIC). This program encourages joint applications from U. S. and low- and middle-income country (LMIC) institutions to develop collaborative training programs that strengthen the capacity of LMIC institutions to conduct infectious disease research.
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) - Fogarty International Center (FIC). This funding opportunity supports exploratory or developmental research studies that identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions.
Notice of Award of a Sole Source Cooperative Agreement To Fund Ministry of Health, Bhutan; National Influenza Center, Mongolia; Research Institute for Tropical Medicine, Philippines; Bangkok Metropolitan Administration, Thailand is sponsored by Health and Human Services Department; Centers for Disease Control and Prevention. The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces four separate awards to fund the Ministry of Health, Bhutan; National Influenza Center, Mongolia; Research Institute for Tropical Medicine, Philippines; Bangkok Metropolitan Administration, Thailand. For Ministry of Health, Bhutan, the award is for approximately $800,000 in Federal Fiscal Year (FFY) 2026, subject to the availability of funds. For National Influenza Center, Mongolia, the award is for approximately $600,000 in FFY 2026, subject to the availability of funds. For Research Institute for Tropical Medicine, Philippines, the award is for approximately $600,000 in FFY 2026, subject to the availability of funds. For Bangkok Metropolitan Administration, Thailand, the award is for approximately $900,000 in FFY 2026, subject to the availability of funds. The total FFY 2026 funding amount for the four recipients is $2,900,000. Funding amounts for years 2-5 for each recipient will be set at continuation. The awards will enhance health security by strengthening global influenza and other priority pathogen surveillance networks to detect and respond to infectious disease threats. Action: Notice. Published in the Federal Register on 2026-08-05. Federal Register document number: 2026-15903.
Notice of Award of a Single Source Cooperative Agreement To Fund Association Institut National Hygiene Publique, Cote d'Ivoire; Ministry of Health-Centers for Disease Control and Prevention, Egypt; Ethiopian Public Health Institute; Noguchi Memorial Institute for Medical Research, Ghana; Institut National d Hygiene, Morocco; Institut Pasteur de Dakar, Senegal; Institut Pasteur de Tunis, Tunisia; Uganda Virus Research Institute; University Teaching Hospital, Zambia is sponsored by Health and Human Services Department; Centers for Disease Control and Prevention. The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces nine separate awards to fund Institut National Hygiene Publique, Cote d'Ivoire; Ministry of Health-Centers for Disease Control and Prevention, Egypt; Ethiopian Public Health Institute; Noguchi Memorial Institute for Medical Research, Ghana; Institut National d Hygiene, Morocco; Institut Pasteur de Dakar, Senegal; Institut Pasteur de Tunis, Tunisia; Uganda Virus Research Institute; University Teaching Hospital, Zambia. For Institut National Hygiene Publique, Cote d'Ivoire, the award is for approximately $800,000 in Federal Fiscal Year (FFY) 2026, subject to the availability of funds. For Ministry of Health-Centers for Disease Control and Prevention, Egypt, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. For Ethiopian Public Health Institute, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. For Noguchi Memorial Institute for Medical Research, Ghana, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. For Institut National d Hygiene, Morocco, the award is for approximately $600,000 in FFY 2026, subject to the availability of funds. For Institut Pasteur de Dakar, Senegal, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. For Institut Pasteur de Tunis, Tunisia, the award is for approximately $600,000 in FFY2026, subject to the availability of funds. For Uganda Virus Research Institute, the award is for approximately $900,000 in FFY 2026, subject to the availability of funds. For University Teaching Hospital, Zambia, the award is for approximately $600,000 in FFY 2026, subject to the availability of funds. The total FFY 2026 amount for the nine recipients is $6,7000,000. Funding amounts for years 2-5 for each recipient will be set at continuation The awards will enhance health security by strengthening global influenza and other priority pathogen surveillance networks to detect and respond to infectious disease threats. Action: Notice. Published in the Federal Register on 2026-08-05. Federal Register document number: 2026-15899.
Notice of Award of a Single Source Cooperative Agreement To Fund Institute of Epidemiology, Disease Control and Research, Bangladesh; National Institute of Public Health, Cambodia; Institut Pasteur de Madagascar; National Health Laboratory Service, South Africa; L.Sakvarelidze National Center for Disease Control and Public Health, Georgia. is sponsored by Health and Human Services Department; Centers for Disease Control and Prevention. The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces five separate awards to fund Institute of Epidemiology, Disease Control and Research, Bangladesh; National Institute of Public Health, Cambodia; Institut Pasteur de Madagascar; National Health Laboratory Service, South Africa; L.Sakvarelidze National Center for Disease Control and Public Health, Georgia. For Institute of Epidemiology, Disease Control and Research, Bangladesh, the award is for approximately $1,000,000 in Federal Fiscal Year (FFY) 2026, subject to the availability of funds. For National Institute of Public Health, Cambodia, the award is for approximately $1,000,000 in FFY 2026, subject to the availability of funds. For Institut Pasteur de Madagascar, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. For National Health Laboratory Service, South Africa, the award is for approximately $1,000,000 in FFY 2026, subject to the availability of funds. For L. Sakvarelidze National Center for Disease Control and Public Health, Georgia, the award is for approximately $800,000 in FFY 2026, subject to the availability of funds. The total FFY 2026 funding amount for the five recipients is $4,600,000. Funding amounts for years 2-5 for each recipient will be set at continuation The awards will enhance health security by strengthening global influenza and other priority pathogen surveillance networks to detect and respond to infectious disease threats. Action: Notice. Published in the Federal Register on 2026-08-07. Federal Register document number: 2026-16110.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article